Gene mabs: a scalable, economic, gene-encoded protective antibody platform against coronavirus - covid-19
Other Transaction IDV Awarded Last action
- Contract number
- HR00112190015
- Awardee
-
Smartpharm Therapeutics, Inc. UEI G4REW3Q16XP1
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $4,818,047.00
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
This Other Transaction IDV was awarded by the Defense Advanced Research Projects Agency on November 23, 2020. With a potential value of $4,818,047, it aims to develop a scalable, economic gene-encoded protective antibody platform against coronavirus - COVID-19. The prime contractor is Smartpharm Therapeutics, Inc.
Under this award, Smartpharm Therapeutics, Inc. will deliver products and services to develop a gene-encoded monoclonal antibody platform for rapid, scalable production of therapeutic antibodies against SARS-CoV-2 and future coronavirus threats. Specifically, the company will design gene-encoded monoclonal antibodies, establish manufacturing processes for rapid production at large scale, and conduct preclinical validation of lead therapeutic candidates. By developing an innovative antibody platform using gene encoding and expression technologies, this Defense Advanced Research Projects Agency award seeks to enable scalable manufacturing capabilities crucial for responding to pandemics through rapid production of effective immunotherapies.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$7,323,820 | |
| Funding Only Action | $343,860 | |
| Original award | $11,798,007 |
Quick answers
Who was awarded contract HR00112190015?
HR00112190015 was awarded to Smartpharm Therapeutics, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on November 23, 2020.
How much is contract HR00112190015 worth?
HR00112190015's own ceiling is $4,818,047.
Was contract HR00112190015 competed?
The extent of competition for HR00112190015 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV